BACKGROUND: Albuminuria is an important marker for chronic kidney disease and progression to end-stage renal disease in the general population; understanding racial and ethnic differences can help inform efforts to reduce health disparities. We sought to estimate independent associations of race/ethnicity with albuminuria to determine whether observed differences were attributable to known kidney disease risk factors. METHODS: This cross-sectional study included 64,161 Kidney Early Evaluation Program (KEEP) participants, 2000-2008, with estimated glomerular filtration rate > or = 60 mL/min/1.73 m(2), not on regular dialysis therapy, and without a previous kidney transplant. Albuminuria (urine albumin-creatinine ratio > or = 30 mg/g) was examined by self-reported race and ethnicity. Covariates were age, sex, educational level, body mass index, diabetes status or glucose level, hypertension status or blood pressure measurement, smoking status, health insurance status, and geographic region. RESULTS: Albuminuria prevalences were 8% (n = 2,303) in whites, 11% (n = 2,310) in African Americans, 9% (n = 730) in Hispanics, 10% (n = 381) in Asians, and 15% (n = 344) in American Indians/Alaska Natives. Compared with whites, odds of albuminuria were higher for all groups after multivariate adjustment. Odds were highest for American Indians/Alaska Natives (adjusted OR, 1.93; 95% CI, 1.70-2.20), then Asians (adjusted OR, 1.42; 95% CI, 1.26-1.61), African Americans (adjusted OR, 1.38; 95% CI, 1.29-1.47), and Hispanics (adjusted OR, 1.19; 95% CI, 1.08-1.31). CONCLUSIONS: In the KEEP study population, albuminuria prevalence was higher in African Americans, Hispanics, Asians, and American Indians/Alaska Natives than in non-Hispanic whites, suggesting a need for screening for early detection of kidney damage, especially in people at increased risk, in the community primary care setting. Copyright (c) 2010 National Kidney Foundation, Inc. All rights reserved.
BACKGROUND:Albuminuria is an important marker for chronic kidney disease and progression to end-stage renal disease in the general population; understanding racial and ethnic differences can help inform efforts to reduce health disparities. We sought to estimate independent associations of race/ethnicity with albuminuria to determine whether observed differences were attributable to known kidney disease risk factors. METHODS: This cross-sectional study included 64,161 Kidney Early Evaluation Program (KEEP) participants, 2000-2008, with estimated glomerular filtration rate > or = 60 mL/min/1.73 m(2), not on regular dialysis therapy, and without a previous kidney transplant. Albuminuria (urine albumin-creatinine ratio > or = 30 mg/g) was examined by self-reported race and ethnicity. Covariates were age, sex, educational level, body mass index, diabetes status or glucose level, hypertension status or blood pressure measurement, smoking status, health insurance status, and geographic region. RESULTS:Albuminuria prevalences were 8% (n = 2,303) in whites, 11% (n = 2,310) in African Americans, 9% (n = 730) in Hispanics, 10% (n = 381) in Asians, and 15% (n = 344) in American Indians/Alaska Natives. Compared with whites, odds of albuminuria were higher for all groups after multivariate adjustment. Odds were highest for American Indians/Alaska Natives (adjusted OR, 1.93; 95% CI, 1.70-2.20), then Asians (adjusted OR, 1.42; 95% CI, 1.26-1.61), African Americans (adjusted OR, 1.38; 95% CI, 1.29-1.47), and Hispanics (adjusted OR, 1.19; 95% CI, 1.08-1.31). CONCLUSIONS: In the KEEP study population, albuminuria prevalence was higher in African Americans, Hispanics, Asians, and American Indians/Alaska Natives than in non-Hispanic whites, suggesting a need for screening for early detection of kidney damage, especially in people at increased risk, in the community primary care setting. Copyright (c) 2010 National Kidney Foundation, Inc. All rights reserved.
Authors: Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick de Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick E Grobbee; Paul E de Jong Journal: Circulation Date: 2002-10-01 Impact factor: 29.690
Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf Journal: JAMA Date: 2001-07-25 Impact factor: 56.272
Authors: Wendy Weinstock Brown; Rosalind M Peters; Suzanne E Ohmit; William F Keane; Allan Collins; Shu-Chen Chen; Karren King; Michael J Klag; Donald A Molony; John M Flack Journal: Am J Kidney Dis Date: 2003-07 Impact factor: 8.860
Authors: Stacey E Jolly; Suying Li; Shu-Cheng Chen; Andrew S Narva; Claudine T Jurkovitz; Keith C Norris; Michael G Shlipak Journal: Am J Nephrol Date: 2008-11-14 Impact factor: 3.754
Authors: Amy K Mottl; Suma Vupputuri; Shelley A Cole; Laura Almasy; Harald H H Göring; Vincent P Diego; Sandra Laston; Nawar Shara; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Jean W MacCluer; Jason G Umans; Kari E North Journal: J Am Soc Nephrol Date: 2009-04-15 Impact factor: 10.121
Authors: Klaus Klausen; Knut Borch-Johnsen; Bo Feldt-Rasmussen; Gorm Jensen; Peter Clausen; Henrik Scharling; Merete Appleyard; Jan Skov Jensen Journal: Circulation Date: 2004-06-21 Impact factor: 29.690
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Michael J Fischer; Jesse Y Hsu; Claudia M Lora; Ana C Ricardo; Amanda H Anderson; Lydia Bazzano; Magdalena M Cuevas; Chi-Yuan Hsu; John W Kusek; Amada Renteria; Akinlolu O Ojo; Dominic S Raj; Sylvia E Rosas; Qiang Pan; Kristine Yaffe; Alan S Go; James P Lash Journal: J Am Soc Nephrol Date: 2016-05-05 Impact factor: 10.121
Authors: William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Reshma Kewalramani; Mary Cushman; Leslie A McClure; Britt B Newsome; George Howard Journal: J Am Soc Nephrol Date: 2011-08-25 Impact factor: 10.121
Authors: Orlando M Gutiérrez; Suzanne E Judd; Paul Muntner; Dana V Rizk; William M McClellan; Monika M Safford; Mary Cushman; Brett M Kissela; Virginia J Howard; David G Warnock Journal: Neurology Date: 2012-09-19 Impact factor: 9.910
Authors: Stacey E Jolly; Nilka Ríos Burrows; Shu-Cheng Chen; Suying Li; Claudine T Jurkovitz; Keith C Norris; Michael G Shlipak Journal: Clin J Am Soc Nephrol Date: 2011-07-22 Impact factor: 8.237
Authors: Deidra C Crews; William M McClellan; David A Shoham; Liyan Gao; David G Warnock; Suzanne Judd; Paul Muntner; Edgar R Miller; Neil R Powe Journal: Am J Kidney Dis Date: 2012-06-12 Impact factor: 8.860
Authors: Andrew S Bomback; Yelena Rekhtman; Adam T Whaley-Connell; Abhijit V Kshirsagar; James R Sowers; Shu-Cheng Chen; Suying Li; Kavitha M Chinnaiyan; George L Bakris; Peter A McCullough Journal: Diabetes Care Date: 2010-08-31 Impact factor: 19.112
Authors: Orlando M Gutiérrez; Yulia A Khodneva; Paul Muntner; Dana V Rizk; William M McClellan; Mary Cushman; David G Warnock; Monika M Safford Journal: JAMA Date: 2013-08-21 Impact factor: 56.272